Ooma Inc: Form 10-Q for the period ended Oct 31, 2024
Filed with the SEC on Dec 10, 2024 and accepted by EDGAR at Dec 9, 2024, 18:14 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2024-10-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2024-08-01 to 2024-10-31 | $65.1m | us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax |
| Revenue | 9 months2024-02-01 to 2024-10-31 | $191.8m | us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax |
| Cost of revenue | 3 months2024-08-01 to 2024-10-31 | $25.9m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months2024-02-01 to 2024-10-31 | $75.7m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2024-08-01 to 2024-10-31 | $39.3m | us-gaap:GrossProfit |
| Gross profit | 9 months2024-02-01 to 2024-10-31 | $116.1m | us-gaap:GrossProfit |
| Research and development | 3 months2024-08-01 to 2024-10-31 | $14.2m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2024-02-01 to 2024-10-31 | $41.7m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2024-08-01 to 2024-10-31 | −$2.3m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2024-02-01 to 2024-10-31 | −$6.6m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2024-08-01 to 2024-10-31 | $92.0k | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2024-02-01 to 2024-10-31 | $855.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2024-08-01 to 2024-10-31 | −$2.4m | us-gaap:NetIncomeLoss |
| Net income | 9 months2024-02-01 to 2024-10-31 | −$6.6m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2024-08-01 to 2024-10-31 | −$0.09 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2024-02-01 to 2024-10-31 | −$0.25 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2024-08-01 to 2024-10-31 | −$0.09 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2024-02-01 to 2024-10-31 | −$0.25 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2024-08-01 to 2024-10-31 | 26,837,594 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2024-02-01 to 2024-10-31 | 26,547,389 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2024-02-01 to 2024-10-31 | $18.8m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2024-02-01 to 2024-10-31 | $4.8m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 9 months2024-02-01 to 2024-10-31 | $2.1m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2024-10-31 | $17.1m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2024-10-31 | $55.1m | us-gaap:AssetsCurrent |
| Total assets | At period end2024-10-31 | $149.6m | us-gaap:Assets |
| Current liabilities | At period end2024-10-31 | $50.9m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2024-10-31 | $66.1m | us-gaap:Liabilities |
| Long-term debt | At period end2024-10-31 | $3.0m | us-gaap:LongTermDebt |
| Shareholders' equity | At period end2024-10-31 | $83.5m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000950170-24-134668. Last ingested by Listed: Oct 27, 2026, 16:11 ET. Listed shows no prices and gives no investment advice.